-

Navigating Global Access, Regulatory Harmonization, and Future Directions in CAR-T Cell Therapy: Insights from a Global Panel Discussion
The Cellular Therapy and Immunotherapy Conference 2025 was successfully held in Hangzhou, China, from November 13-16, 2025. The conference brought together a distinguished gathering of the world’s leading researchers, clinicians, and industry pioneers to share groundbreaking advancements and foster collaboration in the rapidly advancing fields of cellular and immune-based treatments. The morning’s agenda offered a…
-

Prof. Jae-Ho Yoon: Korea’s ALL Management in the Era of Gene Analysis and Targeted Immunotherapy
At the conference, Professor Jae-Ho Yoon from Seoul St. Mary’s Hospital delivered an outstanding presentation titled “Diagnostic and Therapeutic Advances in Korea with Acute Lymphoblastic Leukemia in the Era of…
-

Professor Micha Srour: Advances and Challenges of CAR-T Therapy in CLL | 2025 Conference on Cellular Therapy and Biomedical Frontiers
Editor’s Note: Cellular therapy has emerged as a breakthrough treatment modality, showing remarkable efficacy across various hematologic malignancies. However, its application in chronic lymphocytic leukemia (CLL) continues to face notable…
-

Professor Stefan O. Ciurea: Adoptive Cellular Therapy After Hematopoietic Stem Cell Transplantation
2025 International Conference on Cell Therapy and Biomedical Frontiers Editor’s Note: On October 31, 2025, the International Conference on Cell Therapy and Biomedical Frontiers was successfully held in Xiong’an, Hebei…
-

Prof. Huang Xiaojun: Decoding Homeostatic Remodeling in Haploidentical Hematopoietic Stem Cell Transplantation—From HLA Mismatch to Immune Rebalancing
2025 International Conference on Cell Therapy and Biomedical Frontiers Editor’s Note: On October 31, 2025, the International Conference on Cell Therapy and Biomedical Frontiers was grandly held in Xiong’an, Hebei…
